Recombinant Human CDC42 Protein，His

Cdc42 is a member of the Rho family of small GTPases, which play crucial roles in various cellular processes, including cytoskeletal dynamics, cell migration, and cell cycle regulation. Its dysregulation has been implicated in numerous diseases, including cancer, neurodegenerative disorders, and developmental abnormalities. Research on Cdc42 has gained significant attention due to its pivotal role in regulating actin filament organization and vesicle trafficking. Recombinant Cdc42 proteins are essential tools for studying the molecular mechanisms underlying its functions. These proteins allow researchers to investigate the biochemical properties of Cdc42, including its interactions with downstream effectors and regulatory proteins. Additionally, the use of recombinant Cdc42 facilitates in vitro assays that can elucidate how Cdc42 influences cell behavior, such as morphological changes during the epithelial-to-mesenchymal transition (EMT) and processes involved in cellular signaling pathways. Understanding Cdc42’s function and regulation through recombinant protein studies is fundamental for developing targeted therapeutic strategies that could potentially mitigate the effects of diseases associated with its aberrant activity. Thus, the exploration of Cdc42 recombinant proteins not only advances our understanding of fundamental cellular biology but also holds promise for future biomedical applications.